Drug interactions
Deferasirox + Vincristine liposomal
Severity: Minor
Deferasirox and Vincristine liposomal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Deferasirox may modestly lower vincristine exposure via CYP3A4 induction. The clinical importance is uncertain, and reduced efficacy is only a theoretical concern.
What this interaction means in plain words
Deferasirox and Vincristine liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Possible weak CYP3A4 induction by deferasirox increases vincristine metabolism.
What to do
Monitor treatment response and neurotoxicity; no empirical dose change is needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Vincristine liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Deferasirox
Frequently asked questions
Can I take Deferasirox with Vincristine liposomal?
MediHelp rates the interaction as minor. Deferasirox and Vincristine liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Deferasirox may modestly lower vincristine exposure via CYP3A4 induction. The clinical importance is uncertain, and reduced efficacy is only a theoretical concern.
How serious is the interaction between Deferasirox and Vincristine liposomal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor treatment response and neurotoxicity; no empirical dose change is needed.
What other medicines interact with Deferasirox?
MediHelp also lists interactions of Deferasirox with, for example, Acetylsalicylic acid, Alosetron, Aluminum hydroxide. The full list is on the Deferasirox page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
